Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab. (Q54660064)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab. |
scientific article |
Statements
Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab. (English)
1 reference
Allan Lipton
1 reference
Wolfgang J Köstler
1 reference
Kim Leitzel
1 reference
Suhail M Ali
1 reference
Jeff Sperinde
1 reference
Jodi Weidler
1 reference
Agnes Paquet
1 reference
Thomas Sherwood
1 reference
Weidong Huang
1 reference
Michael Bates
1 reference
Trastuzumab Response Biomarker Group
1 reference
1 November 2010
1 reference
1 reference
116
1 reference
5168-5178
1 reference
22
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference